Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-12-29
2000-07-04
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 23, 514 53, 536 53, 536 551, 536 552, 536 553, A61K 31715, C08B 3700
Patent
active
060839295
ABSTRACT:
A variety of compounds are provided which are usefdl as immunogens and as tumor markers. The present invention discloses methods relating to the detection of cancer. Extended forms of the lacto-series type 1 chain are shown to be present in various cancer tissues. The present invention also provides a cell line and the monoclonal antibody produced therefrom. Such an antibody has a number of uses, including in diagnostic or therapeutic methods.
REFERENCES:
patent: 5011920 (1991-04-01), Hakomori et al.
patent: 5030723 (1991-07-01), Nudelman et al.
Macher et al; J. Biol. Chem. 256(4):1968-1974 (1981), months not available.
Gooi et al; Nature 292:155-158 (1981), months not available.
Dabrowski et al; Arch. Biochem. Biophys. 210(1):405-411 (1981), months not available.
Magnani et al; Cancer Research 43:5489-5492 (1983), months not available.
Childs et al; The EMBO Journal 3(10):2227-2233 (1984), months not available.
Fenderson et al; J. Exp. Med. 160:1591-1596 (1984), months not available.
Kannagi et al; J. Biol. Chem. 260(10):6410-6415 (1985), months not available.
Khare et al; Carb. Res. 136:285-308 (1985), months not available.
Holmes et al; J. Biol. Chem. 260(12):7619-7627 (1985), months not available.
Levery et al; Carb. Res. 151:311-328 (1986), months not available.
Levery et al; Carb. Res. 178:121-144 (1988), months not available.
Holmes et al; Arch. Biochem. Biophys. 274(2):633-647 (Nov. 1. 1989).
Stroud et al; J. Biol. Chem. 266(13):8439-8446 (May 5, 1991).
Bouhours et al; J. Biol. Chem. 266(28): 18613-19 (Oct. 5, 1991).
Iwamori et al. FEBS Letters 1988, 233(1), 134-138, months not available.
Nozawa et al. Cancer Research 1989, 49, 6401-6406, months not available.
Hakomori Sen-itiroh
Levery Steven B.
Stroud Mark R.
Fonda Kathleen K.
The Biomembrane Institute
LandOfFree
Extended type 1 chain glycosphingolipids as tumor-associated ant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extended type 1 chain glycosphingolipids as tumor-associated ant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended type 1 chain glycosphingolipids as tumor-associated ant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486716